CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Impressive effect of cisplatin monotherapy on a patient with heavily pretreated triple-negative breast cancer with poor performance
Dong Won Baek, Ji-Young Park, Soo Jung Lee, Yee Soo Chae

DOI: https://doi.org/10.12701/yujm.2019.00423

Excel Download

Triple-Negative Breast Cancer, Cisplatin and Calpain-1
Breast Cancer and Surgery. 2018;   Crossref logo
Link1

Role of cisplatin and doxorubicin as neoadjuvant in locally advanced triple negative breast cancer
The Breast. 2018;41:S21   Crossref logo
Link1 Link2

Pathologic Evaluation of Triple-Negative Breast Cancer
Triple-Negative Breast Cancer. 2017;1-22   Crossref logo
Link1

Triple-Negative Breast Cancer: Clinical Features
Triple-Negative Breast Cancer. 2017;23-32   Crossref logo
Link1

Oral or intravenous vinorelbine plus capecitabine in heavily pretreated HER2 negative metastatic breast cancer; similar effect or quality of life?
Breast Cancer Research and Treatment. 2019;176(2):477-477   Crossref logo
Link1 Link2 Link3

Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer
Breast Cancer: Targets and Therapy. 2011;101   Crossref logo
Link1

The Genetics of Triple-Negative Breast Cancer
Triple-Negative Breast Cancer. 2017;33-40   Crossref logo
Link1

Surgical Management of Triple-Negative Breast Cancer
Triple-Negative Breast Cancer. 2017;55-69   Crossref logo
Link1

Radiation Therapy for Triple-Negative Breast Cancer
Triple-Negative Breast Cancer. 2017;71-82   Crossref logo
Link1

Management of Metastatic Triple-Negative Breast Cancer
Triple-Negative Breast Cancer. 2017;95-116   Crossref logo
Link1